Article ID: 708178 Next Generation Precision Oncology Symposium Celebrates Survivors, Current and FutureUniversity of California San Diego HealthThe Next Generation Precision Oncology Symposium, a novel meeting of industry and academic leaders in cancer science and medicine, will be held February 21, 2019 at UC San Diego Moores Cancer Center. Released:15-Feb-2019 12:05 PM EST |
![]() Article ID: 707468 Potential to Better Treat Mesothelioma Revealed by Precision Medicine ResearchSbarro Health Research Organization (SHRO)Researchers have successfully identified two genetic markers for potentially effective treatment of Mesothelioma, an orphan disease most commonly associated with asbestos exposure, and for which few treatments exist. Released:4-Feb-2019 11:45 AM EST |
Article ID: 707416 More than 60 Leading Health Care Organizations Call on CMS to Maintain Coverage for Medically Necessary Cancer TestingAssociation for Molecular PathologyLeading health care companies and organizations representing patients, providers, academic medical centers, laboratories, and diagnostic manufacturers urged the Centers for Medicare and Medicaid Services to revise its interpretation of the National Coverage Determination for Next Generation Sequencing. Released:1-Feb-2019 12:00 PM EST |
![]() Article ID: 707271 GW Researchers Call for Big Data Infrastructure to Support Future of Personalized MedicineGeorge Washington UniversityResearchers from the George Washington University , the U.S. Food and Drug Administration, and industry leaders published in PLOS Biology, describing a standardized communication method for researchers performing high-throughput sequencing called BioCompute. Released:30-Jan-2019 12:05 PM ESTChannels: All Journal News, Personalized Medicine, Pharmaceuticals, PLOS ONE, Local - DC, Local - DC Metro george washington university school of medicine and health sciences, Harvard Medical School, FDA, Merck, Personalized Medicine, Genomics, high-throughput sequencing, biocompute object, Plos Biology |
Article ID: 707107 First US Patient in Novel Stem Cell Trial for Stroke Disability Enrolled at UTHealthUniversity of Texas Health Science Center at HoustonThe first U.S. patient to participate in a global study of a stem cell therapy injected directly into the brain to treat stroke disability was enrolled in the clinical trial this week at The University of Texas Health Science Center at Houston (UTHealth). Released:25-Jan-2019 4:05 PM ESTChannels: Neuro, Personalized Medicine, Stem Cells, Local - Texas, Local - Houston Metro Sean Savitz, M.D., Stroke, Stem Cells, ReNeuron, UTHealth Institute for Stroke and Cerebrovascular Disease, Stem Cell Therapy, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Neurology, Stroke Rehabilitation |
Article ID: 706961 Hope for lifeUT Southwestern Medical CenterUT Southwestern Medical Center is helping the Duff family organize a gene therapy clinical trial to treat Talia’s condition, called Charcot Marie Tooth disease, type 4J (CMT4J). Released:23-Jan-2019 3:05 PM EST |
Article ID: 706886 Targeted treatment shrinks deadly pediatric brain tumorsSanford Burnham Prebys Medical Discovery InstituteFor children—whose tiny bodies are still growing—chemotherapy and radiation treatments can cause lifelong damage. Now, scientists at Sanford Burnham Prebys Medical Discovery Institute (SBP) have reported that a targeted therapy that blocks a protein called LSD1 was able to shrink tumors in mice with a form of pediatric brain cancer known as medulloblastoma. LSD1 inhibitors are currently under evaluation in clinical trials for other cancers. The study was published in Nature Communications. Released:23-Jan-2019 8:00 AM EST |
![]() Article ID: 706796 Keeping astronauts healthy during deep space missionsMichigan State UniversityGeorge Mias, Michigan State University biochemistry and molecular biology researcher, believes precision medicine -- a personalized approach using technology to analyze an individual's wellness to predict and possibly prevent illnesses -- can keep astronauts healthy during deep space missions. Released:21-Jan-2019 11:05 AM EST |
Article ID: 706612 Access to Care, Knowledge About Genetic Testing and Clinical Trials Identified as Key Issues in Landmark Survey of Neuromuscular CommunityMuscular Dystrophy Association (MDA)ONEVoice, a landmark survey funded by the Muscular Dystrophy Association (MDA) and conducted by Edge Research, has identified key areas of concern among more than 3,000 respondents – 2,430 adults with neuromuscular disease and 932 caregivers/family members – as well as ways in which many of these concerns can be addressed. Released:17-Jan-2019 9:00 AM EST |
Article ID: 706545 UNLV Startup Uses Genes to Create Personalized DietsUniversity of Nevada, Las Vegas (UNLV)Food Genes and Me is a site and software that lets users figure out health risks and how to solve them within minutes. Released:16-Jan-2019 8:00 AM EST |